News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search

 


More treatment options for Kiwis with type 1 diabetes

Media Release EMBARGOED UNTIL 12:01am, Thursday 17 January 2013

More treatment options for Kiwis with type 1 diabetes now funded

Medtronic insulin pumps and insulin pump consumables now available through PHARMAC

New Zealand diabetes specialists and people with type 1 diabetes have today welcomed the availability of a second supplier to PHARMAC for insulin pumps and insulin pump consumables, citing the availability for choice of device technologies as a significant step forward in improving management of the condition in New Zealand.

Commenting on the addition of Medtronic insulin pumps and insulin pump consumables through PHARMAC, Associate Professor Paul Hofman said: “It cannot be assumed that even though people are diagnosed with the same health condition that one specific device will give everyone the best health outcomes – health management is not a ‘one size fits all’ option. The addition of a second supplier to PHARMAC means that people with type 1 diabetes who qualify for an insulin pump can decide on an option that is most appropriate for their needs."

The MiniMed Paradigm™ Insulin Pump Model 522 or 722 now reimbursed by PHARMAC, provides REALTime glucose readings updated every five minutes, 24 hours a day. These readings help patients take immediate action in the management of their diabetes, reducing the severity and duration of hypo and hyperglycaemiai, ii, iii,iv and protect against longterm health complications associated with these conditions such as eye, heart and kidney disease.v,vi The pump also enables more precise dosing of insulin. This is an important consideration for many people with type 1 diabetes, especially young children, who require small, frequent doses of insulin which are impractical and virtually impossible to deliver via an injection.

“The decision by PHARMAC is a positive step forward in encouraging insulin pump use in New Zealand and I hope it prompts children, families and adults with type 1 diabetes to discuss this therapy option with their general practioners or diabetes team specialists,” said Assoc Prof Hofman “An insulin pump may be the right choice for anyone who takes insulin and wants better glucose control, more convenience and more flexibility to improve their quality of life."

Research shows that people on insulin pump therapy are six times more likely to achieve the target HbA1c (Glycated Haemoglobin) level than people on multiple daily injections with long acting insulin. This is important given that people with diabetes who keep their glucose at nearnormal levels significantly reduce their risk of longterm complications to live healthier and longer.

For patients who have previously purchased a Medtronic pump at their own cost, the decision now means they can access reservoirs and infusion sets that work in conjunction with their pump to delivery therapy, through pharmacies at no charge.

Amy DaneshClough, parent of 11 year old Jonnie, who has been diagnosed with type 1 diabetes for ten years and currently uses an insulin pump, believes the funding is a step forward in bringing New Zealand in line with the rest of the world – but still there is a long way to go.

“We have attended family camps for children with type 1 diabetes overseas where 95 per cent of the children have an insulin pump to manage their diabetes and only a small number use multiple daily injections. I believe the reverse is true in New Zealand, largely due to the cost of accessing the therapy.

“While we have paid for an insulin pump ourselves, funding for the ongoing consumables will be a great saving for us and I hope will enable more people with type 1 diabetes to access this therapy."

People who meet the PHARMAC eligibility criteria and are approved, will have access to fully funded Medtronic pumps and consumables via pharmacies. For full details on the criteria please visit http://www.pharmac.govt.nz

ENDS

i Bode BW, et al. Diabetes Research and Clin Practice.1999;46:18390.

ii Kaufman FR, et al. DiabetesCare. 2001;24(12):2030.

iii Ludvigsson J, et al. Pediatrics. 2003;111(5 Pt 1):9338.

iv Bode B, et al. Diabetes Technol Ther.2004;6(2):10513.

v Australian Type 1 Diabetes Research Agenda, Juvenile Diabetes Research Foundation, Sydney, 2010.

vi Australian Healthcare Associates Final Report: Insulin Pump Review, 2008.


© Scoop Media

 
 
 
 
 
Culture Headlines | Health Headlines | Education Headlines

 
Werewolf: Katniss Joins The News Team

From the outset, the Hunger Games series has dwelt obsessively on the ways that media images infiltrate our public and personal lives... From that grim starting point, Mockingjay Part One takes the process a few stages further. There is very little of the film that does not involve the characters (a) being on screens (b) making propaganda footage to be screened and (c) reacting to what other characters have been doing on screens. More>>

ALSO:

Scoop Review Of Books: Ko Witi Te Kaituhituhi

Witi Ihimaera, the distinguished Māori author and the first Māori to publish a book of short stories and a novel, has adopted a new genre with his latest book. But despite its subtitle, this book is a great deal more than a memoir of childhood. More>>

Werewolf: Rescuing Paul Robeson

Would it be any harder these days, for the US government to destroy the career of a famous American entertainer and disappear them from history – purely because of their political beliefs? You would hope so. In 1940, Paul Robeson – a gifted black athlete, singer, film star, Shakespearean actor and orator – was one of the most beloved entertainers on the planet. More>>

ALSO:

"Not A Competition... A Quest": Chapman Tripp Theatre Award Winners

Big winners on the night were Equivocation (Promising Newcomer, Best Costume, Best Director and Production of the Year), Kiss the Fish (Best Music Composition, Outstanding New NZ Play and Best Supporting Actress), and Watch (Best Set, Best Sound Design and Outstanding Performance). More>>

ALSO:

Film Awards: The Dark Horse Scores Big

An inspirational film based on real life Gisborne speed-chess coach An inspirational film based on real life Gisborne speed-chess coach Genesis Potini, made all the right moves to take out top honours along with five other awards at the Rialto Channel New Zealand Film Awards - nicknamed The Moas. More>>

ALSO:

Theatre: Ralph McCubbin Howell Wins 2014 Bruce Mason Award

The Bruce Mason Playwriting Award was presented to Ralph McCubbin Howell at the Playmarket Accolades in Wellington on 23 November 2014. More>>

ALSO:

One Good Tern: Fairy Tern Crowned NZ Seabird Of The Year

The fairy tern and the Fiji petrel traded the lead in the poll several times. But a late surge saw it come out on top with 1882 votes. The Fiji petrel won 1801 votes, and 563 people voted for the little blue penguin. More>>

Music Awards: Lorde Reigns Supreme

Following a hugely successful year locally and internationally, Lorde has done it again taking out no less than six Tuis at the 49th annual Vodafone New Zealand Music Awards. More>>

ALSO:

Get More From Scoop

 
 

LATEST HEADLINES

 
 
 
 
Health
Search Scoop  
 
 
Powered by Vodafone
NZ independent news